Worldwide, the average value of enterprise value to earnings before interest, tax, depreciation and amortization (EV/EBITDA) in the health & pharmaceuticals sector as of 2020, was a multiple of approximately 16.7x. Healthcare information and technology companies saw the highest average valuation multiples as of January 2020 with 24.8x.
Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide in 2019 and 2020, by industry
Worldwide. * All companies (excluding financial). Health & Pharmaceuticals 2019=3,779 2020=4,023.
Enterprise value = Market value of equity + Market value of debt - Cash. EBITDA = Estimated by adding depreciation and amortization back to operating income (EBIT). Only positive EBITDA firms.
Profit from additional features by authenticating your Admin account
Please authenticate by going to "My account" → "Administration".
Then you will be able to mark statistics as favourites and use personal statistics alerts.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59$39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract; Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Leonard N. Stern School of Business. (January 5, 2020). Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide in 2019 and 2020, by industry [Graph]. In Statista. Retrieved September 18, 2020, from https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business. "Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide in 2019 and 2020, by industry." Chart. January 5, 2020. Statista. Accessed September 18, 2020. https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business. (2020). Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide in 2019 and 2020, by industry. Statista. Statista Inc.. Accessed: September 18, 2020. https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business. "Average Ev/Ebitda Multiples in The Health & Pharmaceuticals Sector Worldwide in 2019 and 2020, by Industry." Statista, Statista Inc., 5 Jan 2020, https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business, Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide in 2019 and 2020, by industry Statista, https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/ (last visited September 18, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
